These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 21304261)

  • 1. [Metabolic syndrome and nephrolithiasis].
    Kohjimoto Y; Iba A; Sasaki Y; Hara I
    Hinyokika Kiyo; 2011 Jan; 57(1):43-7. PubMed ID: 21304261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of metabolic syndrome traits and severity of kidney stones: results from a nationwide survey on urolithiasis in Japan.
    Kohjimoto Y; Sasaki Y; Iguchi M; Matsumura N; Inagaki T; Hara I
    Am J Kidney Dis; 2013 Jun; 61(6):923-9. PubMed ID: 23433467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The metabolic syndrome and uric acid nephrolithiasis: novel features of renal manifestation of insulin resistance.
    Abate N; Chandalia M; Cabo-Chan AV; Moe OW; Sakhaee K
    Kidney Int; 2004 Feb; 65(2):386-92. PubMed ID: 14717908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic syndrome and uric acid nephrolithiasis.
    Sakhaee K; Maalouf NM
    Semin Nephrol; 2008 Mar; 28(2):174-80. PubMed ID: 18359398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
    Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
    Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic syndrome: a multifaceted risk factor for kidney stones.
    Domingos F; Serra A
    Scand J Urol; 2014 Oct; 48(5):414-9. PubMed ID: 24708398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Urine Findings with Metabolic Syndrome Traits in a Population of Patients with Nephrolithiasis.
    Hood VL; Sternberg KM; de Waal D; Asplin JR; Mulligan C; Callas PW
    Kidney360; 2022 Feb; 3(2):317-324. PubMed ID: 35373120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Body size and 24-hour urine composition.
    Taylor EN; Curhan GC
    Am J Kidney Dis; 2006 Dec; 48(6):905-15. PubMed ID: 17162145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristic clinical and biochemical profile of recurrent calcium-oxalate nephrolithiasis in patients with metabolic syndrome.
    Rendina D; De Filippo G; Zampa G; Muscariello R; Mossetti G; Strazzullo P
    Nephrol Dial Transplant; 2011 Jul; 26(7):2256-63. PubMed ID: 21051502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin resistance and low urinary citrate excretion in calcium stone formers.
    Cupisti A; Meola M; D'Alessandro C; Bernabini G; Pasquali E; Carpi A; Barsotti G
    Biomed Pharmacother; 2007 Jan; 61(1):86-90. PubMed ID: 17184967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of overweight and obesity on the urinary excretion of promoters and inhibitors of stone formation in stone formers.
    Negri AL; Spivacow FR; Del Valle EE; Forrester M; Rosende G; Pinduli I
    Urol Res; 2008 Dec; 36(6):303-7. PubMed ID: 18985334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of overweight and obesity in calcium oxalate stone formation.
    Siener R; Glatz S; Nicolay C; Hesse A
    Obes Res; 2004 Jan; 12(1):106-13. PubMed ID: 14742848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 24-h uric acid excretion and the risk of kidney stones.
    Curhan GC; Taylor EN
    Kidney Int; 2008 Feb; 73(4):489-96. PubMed ID: 18059457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic syndrome and urinary stone composition: what factors matter most?
    Kadlec AO; Greco K; Fridirici ZC; Hart ST; Vellos T; Turk TM
    Urology; 2012 Oct; 80(4):805-10. PubMed ID: 22795374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Weight loss intervention reduces the risk of kidney stone formation in a rat model of metabolic syndrome.
    Sasaki Y; Kohjimoto Y; Iba A; Matsumura N; Hara I
    Int J Urol; 2015 Apr; 22(4):404-9. PubMed ID: 25586245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic syndrome in obese adolescents is associated with risk for nephrolithiasis.
    Tiwari R; Campfield T; Wittcopp C; Braden G; Visintainer P; Reiter EO; Allen HF
    J Pediatr; 2012 Apr; 160(4):615-620.e2. PubMed ID: 22099686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical studies on the recurrence of urolithiasis: (1). Influence of diet on urinary excretion of the stone forming constituents].
    Murayama T; Taguchi H
    Hinyokika Kiyo; 1987 Sep; 33(9):1321-30. PubMed ID: 3434487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Body fat content and distribution and urinary risk factors for nephrolithiasis.
    Pigna F; Sakhaee K; Adams-Huet B; Maalouf NM
    Clin J Am Soc Nephrol; 2014 Jan; 9(1):159-65. PubMed ID: 24202136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Nephrolithiasis in patients with intestinal diseases].
    Cirillo M; Iudici M; Marcarelli F; Laudato M; Zincone F
    G Ital Nefrol; 2008; 25(1):42-8. PubMed ID: 18264917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Potassium Citrate on Calcium Phosphate Stones in a Model of Hypercalciuria.
    Krieger NS; Asplin JR; Frick KK; Granja I; Culbertson CD; Ng A; Grynpas MD; Bushinsky DA
    J Am Soc Nephrol; 2015 Dec; 26(12):3001-8. PubMed ID: 25855777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.